+16.6%
DKS vs BBIO
+42.7%
-26.1%
-48.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | -0.1% | +2.5% | +2.4% |
| 7D | -2.0% | -3.2% | +1.2% | -1.8% |
| 30D | -32.7% | -13.6% | -19.1% | -31.9% |
| 3M | -38.8% | +7.2% | -46.0% | -39.3% |
| 6M | -29.4% | +1.5% | -30.9% | -29.7% |
| YTD | -30.3% | -5.3% | -25.0% | -30.4% |
| 1Y | -39.6% | +37.7% | -77.3% | -41.8% |
| 3Y | +32.2% | +153.9% | -121.7% | +18.2% |
| All | +16.6% | +42.7% | -26.1% | -14.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling